Literature DB >> 29306988

Acute phase response after fatal traumatic brain injury.

Benjamin Ondruschka1, Sandra Schuch2, Dirk Pohlers3, Heike Franke4, Jan Dreßler2.   

Abstract

An inflammatory response occurring after fatal traumatic brain injury (TBI) initiates time-dependent cascades of acute phase response. This may offer the potential to monitor postmortem biomarker levels of several pro-inflammatory cytokines to gain information about the cause of death and the trauma survival time. Cerebrospinal fluid (CSF) and serum samples were collected from forensic autopsies of 95 adult cadavers after postmortem intervals up to 6 days. The cases were divided according to their cause of death into fatal TBI (n = 46) with different survival times and age- and gender-matching non-TBI fatalities as controls (n = 49). Quantitative marker levels of interleukin-6 (IL-6), ferritin, soluble tumor necrosis factor receptor type 1, C-reactive protein, and lactate dehydrogenase were analyzed using immunoassays. Standardized statistical tests were performed to differentiate causes of death and survival time of TBI cases. The CSF IL-6, ferritin, and LDH levels after TBI were significantly higher than those in the controls (p < 0.001). Only serum IL-6 values showed comparable differences (p < 0.05). Both CSF and serum ferritin levels were discriminative between early and delayed death after TBI (p < 0.05). There were partly distinctive correlations between marker levels in both fluids with rising values after longer survival. There were up to moderate correlation between the marker levels and the postmortem interval due to postmortem hemolysis. However, neither CSF nor serum level ranges were affected by the age or gender of the subjects. This study is the first to measure all five proteins systematically in postmortem trauma cases. Ferritin and IL-6 proved themselves to be interesting postmortem biomarkers to provide specific information on the injury pattern and the survival time of traumatic fatalities. Such forensic investigations could serve as inexpensive and fast laboratory tests.

Entities:  

Keywords:  Acute phase response; Cytokines; Fatal traumatic brain injury; Inflammation; Postmortem biochemistry

Mesh:

Substances:

Year:  2018        PMID: 29306988     DOI: 10.1007/s00414-017-1768-2

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  50 in total

Review 1.  Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.

Authors:  Adel Helmy; Maria-Grazia De Simoni; Mathew R Guilfoyle; Keri L H Carpenter; Peter J Hutchinson
Journal:  Prog Neurobiol       Date:  2011-09-16       Impact factor: 11.685

2.  Neuronal apoptosis following human brain injury.

Authors:  R Hausmann; T Biermann; I Wiest; J Tübel; P Betz
Journal:  Int J Legal Med       Date:  2003-11-18       Impact factor: 2.686

3.  The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma.

Authors:  T Taniguchi; Y Koido; J Aiboshi; T Yamashita; S Suzaki; A Kurokawa
Journal:  Am J Emerg Med       Date:  1999-10       Impact factor: 2.469

4.  The effect of brain injury on the inflammatory response following severe trauma.

Authors:  T Lustenberger; M Kern; B Relja; S Wutzler; P Störmann; I Marzi
Journal:  Immunobiology       Date:  2015-11-27       Impact factor: 3.144

Review 5.  Epidemiology of traumatic brain injury.

Authors:  Mark Faul; Victor Coronado
Journal:  Handb Clin Neurol       Date:  2015

Review 6.  Iron, oxidative stress and early neurological deterioration in ischemic stroke.

Authors:  T Carbonell; R Rama
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

7.  Increased expression of ferritin in cerebral cortex after human traumatic brain injury.

Authors:  Huan-Dong Liu; Wei Li; Zhen-Rui Chen; Meng-Liang Zhou; Zong Zhuang; Ding-Ding Zhang; Lin Zhu; Chun-Hua Hang
Journal:  Neurol Sci       Date:  2012-10-19       Impact factor: 3.307

8.  Immunohistochemical investigation of S100 and NSE in cases of traumatic brain injury and its application for survival time determination.

Authors:  Michael Krohn; Jan Dreßler; Manfred Bauer; Kristin Schober; Heike Franke; Benjamin Ondruschka
Journal:  J Neurotrauma       Date:  2015-02-04       Impact factor: 5.269

9.  Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries.

Authors:  T Kossmann; V H Hans; H G Imhof; R Stocker; P Grob; O Trentz; C Morganti-Kossmann
Journal:  Shock       Date:  1995-11       Impact factor: 3.454

10.  The Th1 versus Th2 cytokine profile in cerebrospinal fluid after severe traumatic brain injury in infants and children.

Authors:  Jonathan E. Amick; Kristin A. Yandora; Michael J. Bell; Stephen R. Wisniewski; P. David Adelson; Joseph A. Carcillo; Keri L. Janesko; Steven T. DeKosky; Timothy M. Carlos; Robert S.B. Clark; Patrick M. Kochanek
Journal:  Pediatr Crit Care Med       Date:  2001-07       Impact factor: 3.624

View more
  15 in total

1.  Updating the risk profile of fatal head trauma: an autopsy study with focus on age- and sex-dependent differences.

Authors:  Katharina Kronsbein; Bernd Karger; Jan Budczies; Heidi Pfeiffer; Daniel Wittschieber
Journal:  Int J Legal Med       Date:  2019-11-18       Impact factor: 2.686

2.  Analysis of the risk of traumatic brain injury and evaluation neurogranin and myelin basic protein as potential biomarkers of traumatic brain injury in postmortem examination.

Authors:  Yanjie Shang; Yuxin Wang; Yadong Guo; Lipin Ren; Xiangyan Zhang; Shujuan Wang; Changquan Zhang; Jifeng Cai
Journal:  Forensic Sci Med Pathol       Date:  2022-02-24       Impact factor: 2.456

3.  Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.

Authors:  Benjamin Ondruschka; Lina Woydt; Michael Bernhard; Heike Franke; Holger Kirsten; Sabine Löffler; Dirk Pohlers; Niels Hammer; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-08-30       Impact factor: 2.686

Review 4.  Neuroinflammatory mechanisms of post-traumatic epilepsy.

Authors:  Sanjib Mukherjee; Gabriel M Arisi; Kaley Mims; Gabriela Hollingsworth; Katherine O'Neil; Lee A Shapiro
Journal:  J Neuroinflammation       Date:  2020-06-17       Impact factor: 8.322

5.  Ultrasensitive haptoglobin biomarker detection based on amplified chemiluminescence of magnetite nanoparticles.

Authors:  Narsingh R Nirala; Yifat Harel; Jean-Paul Lellouche; Giorgi Shtenberg
Journal:  J Nanobiotechnology       Date:  2020-01-07       Impact factor: 10.435

6.  Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system-related pathological processes.

Authors:  Benjamin Ondruschka; Michael Bohnert; Simone Bohnert; Christoph Reinert; Stefanie Trella; Werner Schmitz
Journal:  Int J Legal Med       Date:  2020-11-12       Impact factor: 2.686

7.  TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination.

Authors:  Simone Bohnert; Anja Seiffert; Stefanie Trella; Michael Bohnert; Luitpold Distel; Benjamin Ondruschka; Camelia-Maria Monoranu
Journal:  Int J Legal Med       Date:  2020-07-27       Impact factor: 2.686

Review 8.  Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy.

Authors:  Shengxian Li; Yong Huang
Journal:  Clin Transl Oncol       Date:  2021-06-23       Impact factor: 3.340

9.  Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Michael Bohnert; Simone Bohnert; Christoph Wirth; Werner Schmitz; Stefanie Trella; Camelia-Maria Monoranu
Journal:  Int J Legal Med       Date:  2021-04-24       Impact factor: 2.686

10.  Intra-individual alterations of serum markers routinely used in forensic pathology depending on increasing post-mortem interval.

Authors:  Lina Woydt; Michael Bernhard; Holger Kirsten; Ralph Burkhardt; Niels Hammer; André Gries; Jan Dreßler; Benjamin Ondruschka
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.